Matthew Davids, MD from Dana-Farber Cancer Institute, Boston, MA outlines the differences in the treatment of older and younger patients.…
Browsing: Acute Lymphoblastic Leukemia
Owen O’Connor, MD, PhD from Columbia University Medical Center, New York, NY discusses his colleague Dr George Tangs investigation into…
Matthew Davids, MD from Dana-Farber Cancer Institute, Boston, MA outlines the poster demonstrating preliminary results from an investigator initiated study…
Owen O’Connor, MD, PhD from Columbia University Medical Center, New York, NY outlines his presentation on the updates from the…
Davide Rossi, MD, PhD from University of Eastern Piedmont, Vercelli, Italy outlines the novel treatment options for chronic lymphocytic leukemia…
Matthew Davids, MD, from Dana-Farber Cancer Institute, Boston, MA outlines the importance of being aware of a patient’s tumor lysis…
Matthew Davids, MD from Dana-Farber Cancer Institute, Boston, MA outlines the poster demonstrating the safety analysis of venetoclax, BCL-2 inhibitor,…
Anton Hagenbeek, MD, PhD from the University of Amsterdam, Amsterdam, Netherlands discusses how he hopes the treatment of cancer will…
Anton Hagenbeek, MD, PhD from the University of Amsterdam, Amsterdam, Netherlands talks about the issue of drug costs in oncology.…
Anton Hagenbeek, MD, PhD from the University of Amsterdam, Amsterdam, Netherlands discusses how he hopes the treatment of cancer will…
Immunotherapy is a groundbreaking therapy for solid tumors. Where are we with using immunotherapy to treat multiple myeloma? Myeloma expert…
Should patients consider participating in a clinical trial? Andrew Schorr, Patient Power founder and host, leads a discussion with advanced…
Should patients consider participating in a clinical trial? Andrew Schorr, Patient Power founder and host, leads a discussion with advanced…
Eduardo Rego, MD, PhD from University of São Paulo, Brazil discusses coagulopathy in acute myeloid leukemia (AML) at the European…
Eduardo Rego, MD, PhD from University of São Paulo, Brazil discusses the main challenges, primarily bleeding, practitioners face when treating…
Eduardo Rego, MD, PhD from University of São Paulo, Brazil outlines his presentation on his experience with networking as a…
Eduardo Rego, MD, PhD from University of São Paulo, Brazil outlines his presentation on his experience with networking as a…
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany outlines the format of the annual workshop of the German CLL…
Jean-Jacques Kiladjian, MD, PhD from Saint-Louis Hospital & Paris Diderot University, Paris, France discusses the impact of patients registries on…
Jean-Jacques Kiladjian, MD, PhD from Saint-Louis Hospital & Paris Diderot University, Paris, France discusses a selection of topics covered during…
Significant advances have elevated breast cancer care to new levels of success and complexity. One such advance has been the…
Significant advances have elevated breast cancer care to new levels of success and complexity. One such advance has been the…
Significant advances have elevated breast cancer care to new levels of success and complexity. One such advance has been the…
Significant advances have elevated breast cancer care to new levels of success and complexity. One such advance has been the…
Andrew Zelenetz, MD, PhD, from Memorial Sloan-Kettering Cancer Center, New York, NY discusses the results of a Phase III trial…
Irene Ghobrial, MD of the Dana-Farber Cancer Institute (DFCI), discusses progression of multiple myeloma (MM), which comes from conditions such…
Howard Burris, MD from Sarah Cannon, Nashville, TN discusses the use and benefits of liquid biopsies, which include being less…
Howard Burris, MD from Sarah Cannon, Nashville, TN discusses TGR-1202 for chronic lymphocytic leukemia (CLL) and Non-Hodgkin lymphoma (NHL). TGR-1202…
Andrew Zelenetz, MD, PhD, from Memorial Sloan-Kettering Cancer Center, New York, NY discusses the results of a Phase III trial…
Charles Craddock, CBE, FRCP, FRCPath, DPhil, from Queen Elizabeth Hospital, Birmingham, UK explains how the definition of elderly is less…
Jae Park, MD from Memorial Sloan Kettering Cancer Center, New York, NY discusses current research in acute lymphoblastic leukemia (ALL).…
Jacqueline Barrientos, MD from Northwell Health, New York, NY discusses drug treatment options for chronic lymphocytic leukemia (CLL), specifically ibrutinib,…
Jacqueline Barrientos, MD from Northwell Health, New York, NY discuss a placebo-controlled study of idelalisib in combination with bendamustine plus…
Haifa Kathrin Al-Ali, MD from University of Leipzig, Leipzig, Germany discusses the unmet medical need of patients with polycythemia vera…
Haifa Kathrin Al-Ali, MD from University of Leipzig, Leipzig, Germany discusses Momelotinib at the European Hematology Association (EHA) 2016 Annual…
Bruno Paiva, PhD from the University of Navarra, Pamplona, Spain outlines his presentation on the role of minimal residual disease…
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany outlines tumor lysis syndrome as a side-effect of venetoclax in treatment…
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany outlines current clinical research in chronic lymphocytic leukemia (CLL). Dr Eichhorst…
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany discusses the economic burden of treating chronic lymphocytic leukemia (CLL). A…
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany discusses using venetoclax in the treatment of patients with chronic lymphocytic…
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany discusses updates in current clinical trials being undertaken in the field…
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany discusses the treatment of elderly CLL patients. In the beginning of…
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany discussing treatment options for co-morbid chronic lymphocytic leukemia (CLL) patients. These…
Are any immunotherapy approaches currently available to treat advanced prostate cancer patients? Andrew Schorr, Patient Power Founder and Host, leads…
Haifa Kathrin Al-Ali, MD from University of Leipzig, Leipzig, Germany discusses momelotinib at the European Hematology Association (EHA) 2016 Annual…
Robin Foà , MD from the Sapienza University, Rome, Italy gives an overview of the session on ‘Biosimilars: shaping the future…
Klaus Okkenhaug, PhD from Babraham Institute, Cambridge, UK discusses alternative options for the treatment for chronic lymphocytic leukemia (CLL). Similar…
Mohamad Mohty, MD, PhD from Saint-Antoine Hospital, Paris, France discusses the current progress being made in multiple myeloma (MM) research.…
Jae Park, MD from Memorial Sloan Kettering Cancer Center, New York, NY discusses the efficacy and safety of the CD19…